Replies to post #330345 on Avid Bioservices Inc (CDMO)

[biopharm]

Columbia University must like those PS Targeting research with Akiva Mintz and from Wake Forest School of Medicine to Columbia and he was welcomed because of PS Targeting

Much is being discovered right now and Stafford brought in to shake things up it seems. He certainly lied about the value of PS Targeting and Stafford friends can't even announce a deal on time

Notice how ALL involved with PS Targeting translational knowledge have been given better prestige jobs / patents bought out / made CEOs of companies / the list is endless, even our own Jeanette Bleecker that got caught with the sabotage of phase II at CSM with CEO Gerald Finken all got promotions and $$$$

Heck, we even have an ex Perehrine analyst in Rahul that knew the value of PS Targeting, then promptly made CEO over at Heat Biologics or sub Pelican Therapeutics ...and silenced for now.

Attorney General of CT already hot on the trail of Teva and friends colluding in prices and Merck and friends stomping on PS Targeting are in line for some major headlines

[Namtro]

Man did I need and appreciate this recap/summary...
I did start to have doubts, thinking this recent tanking was telling me to exit stage right.
Truly grateful for your recap!

[jakedogman1]

from linked in... https://www.linkedin.com/in/roger-lias/

Lias has been around Raleigh at least since 2002 .... one can get a great house in research triangle area for $500k whereas that will get you a 1200 sf fixer upper in socal... if one likes raleigh which is laid back and nice, it would be a terrible move to socal... particularly at his age where he prob has all the money he needs...

per linkedin, this guy endorsed roger... andrew sandford at catalent pharma.... catalent bought cook which was the other supplier for halo.... catalent would be a logical buyer given the halo connections... if you look at cc transcripts, biologics is one of their fastest growing segments

and catalent would know all about halo ramp up.... i would want the halo biz with the 8 to 10 big pharma partners and all the possibilities w/ enhaze.. gets your foot in the door... 10 to 20 shots on goal w/ trials and commercialization...

could a deal be in the works and roger leaving was a way to tube the share price for the short term? ... mgmt sure has not done anything to stop the bleeding.... why? and if a deal was in the works, roger is no longer needed.... me thinks mgmt wants someone else besides retail to own shares